Class 1. Persistent Pulmonary Hypertension of the Newborn

Sildenafil as Bridge Therapy for Inhaled Nitric Oxide in Preterm Neonates

Harris Khawaja, Timothy A. Sanders, Michael Schreiber, Deborah Bondi, Pooja Shah, Gillian BrennanUniversity of Chicago Medicine and Comer Children’s Hospital.United States Journal of Pediatric Pharmacology and TherapeuticsJ Pediatr Pharmacol Ther 2024; 25: 525-529DOI: 10.5863/1551-6776-29.5.525 AbstractObjective: Inhaled nitric oxide (iNO) is a mainstay of treatment for infants with persistent pulmonary hypertension. However, abrupt discontinuation of inhaled nitric oxide […]

Sildenafil as Bridge Therapy for Inhaled Nitric Oxide in Preterm Neonates Read More »

Pharmacoepidemiology of combination pulmonary vasodilator therapy in critically ill infants

Karan R. Kumar, Elizabeth C. Ciociola, Kayla R. Skinner, Gargi M. Dixit, Sunshine Alvarez, Elijah K. Benjamin, Jeffrey C. Faulkner, Rachel G. Greenberg, Reese H. Clark, Daniel K. Benjamin Jr, Christoph P. Hornik, Jan Hau LeeDuke University School of Medicine. University of North Carolina School of Medicine. Pediatrix Center for Research. KK Women’s and Children’s

Pharmacoepidemiology of combination pulmonary vasodilator therapy in critically ill infants Read More »

Association of Right Ventricular Dysfunction with Risk of Neurodevelopmental Impairment in Infants with Pulmonary Hypertension

Rossana Romero Orozco, Tazuddin A. Mohammed, Kerri Carter, Shaaron Brown, Stephen Miller, Roy T. Sabo, Meredith Campbell Joseph, Uyen Truong, Megha Nair, Victoria Anderson, Jie Xu, Judith A. Voynow, Karen D. Hendricks-MuñozChildren’s Hospital of Richmond at VCU and Virginia Commonwealth University School of Medicine. UF Health Shands Children’s Hospital and University of Florida.  Children’s National

Association of Right Ventricular Dysfunction with Risk of Neurodevelopmental Impairment in Infants with Pulmonary Hypertension Read More »

Echocardiographic Predictors of Hospital Outcomes in Preterm Neonates with Patent Ductus Arteriosus and Clinical Suspicion of Pulmonary Hypertension

Kristen Graff, Julie R. Ross, Kristen Morella, Shahryar M. ChowdhuryMedical University of South Carolina.United States Journal of NeonatologyJ Neonatol 2023; 37: 384-389DOI: 10.1177/09732179231178127 AbstractBackground: Preterm neonates often have an echocardiogram performed in the first few days of life for suspicion of pulmonary hypertension and patent ductus arteriosus. The usefulness of this echocardiogram in predicting outcomes in this

Echocardiographic Predictors of Hospital Outcomes in Preterm Neonates with Patent Ductus Arteriosus and Clinical Suspicion of Pulmonary Hypertension Read More »

Echocardiographic markers at diagnosis of persistent pulmonary hypertension of the newborn

Sujith S. Pereira, Xander Jacquemyn, Shelby KuttyHomerton University Hospital and Homerton Healthcare NHS Foundation Trust. Barts and the London School of Medicine. Johns Hopkins Hospital. KU Leuven.United Kingdom, United States and Belgium Journal of Perinatal MedicineJ Perinat Med 2024; DOI: 10.1515/jpm-2023-0346 AbstractObjectives: Clinical parameters along with echocardiographic markers are used to interrogate the haemodynamics in persistent pulmonary

Echocardiographic markers at diagnosis of persistent pulmonary hypertension of the newborn Read More »

Caesarean section and respiratory system disorders in newborns

Maryam Yeganegi, Nazanin Hajizadeh, Reza Bahrami, Sepideh Azizi, Seyed Reza Mirjalili, Zahra Marzbanrad, Maryam Saeida-Ardekani Mohamad Hosein Lookzadeh, Kamran Alijanpour, Maryam Aghasipour Mohammad Golshan-Tafti, Mahmood Noorishadkam, Hossein NeamatzadehIranshahr University of Medical Sciences. Shiraz University of Medical Sciences. Iran University of Medical Sciences. Firoozgar Hospital. Imam Hossein Hospital and Shahid Beheshti University of Medical Sciences. Shahid

Caesarean section and respiratory system disorders in newborns Read More »

Relationship Between Urine Serotonin and Persistent Pulmonary Hypertension of the Newborn

Jamie L. Archambault, Teri L. Hernandez, Eva S. Nozik, Claire Palmer, Mairead Dillon, Ravinder J. Singh, Csabo Galambos, Cassidy A. DelaneyUniversity of Colorado. Mayo Clinic College of Medicine.United States Journal of PediatricsJ Pediatr 2024; DOI: 10.1016/j.jpeds.2024.114290 AbstractUrine serotonin (5-HT)/creatinine was lower at day of life 3 in newborns with pulmonary hypertension compared with controls, while the

Relationship Between Urine Serotonin and Persistent Pulmonary Hypertension of the Newborn Read More »

Congenital cytomegalovirus and pulmonary hypertension

Layah Alkoby-Meshulam, Jacob Amir, Daniel Lubin, Gil Klinger, Giora Guttesman, Samuel Zangen, Efraim BilavskySchneider Children’s Medical Center. Tel Aviv University. Mayanei Hayeshua Medical Center. Meir Medical Center. Barzilai Medical Center.Israel Congenital AnomaliesCongenit Anom 2024;DOI: 10.1111/cga.12580 AbstractLung involvement in children with congenital cytomegalovirus infection has been scarcely described. We describe three new cases of persistent pulmonary hypertension

Congenital cytomegalovirus and pulmonary hypertension Read More »

Persistent pulmonary hypertension and short-term neurological outcomes in infants with moderate to severe hypoxic ischemic encephalopathy

R. Ismail, Erika Vorhies, K. Mohammad, Amuchou Soraisham, J. Scott, Amelie StritzkeCumming School of Medicine. University of Calgary. Libin Cardiovascular Institute of Alberta. Canada Journal of Neonatal-Perinatal MedicineJ Neonatal Perinatal Med 2024; 17: 597-605DOI: 10.3233/NPM-230032 AbstractBackground: Our aim was to investigate the relationship between persistent pulmonary hypertension of the newborn (PPHN), short-term brain injury or death, and

Persistent pulmonary hypertension and short-term neurological outcomes in infants with moderate to severe hypoxic ischemic encephalopathy Read More »

Intravenous magnesium sulfate in pulmonary hypertension of the newborn: a systematic review

G. Cuttone, C. Minardi, G. Baronti, C. Zanza, Y. Longhitano, L. La ViaASP Trapani.Italy European Review for Medical and Pharmacological SciencesEur Rev Med Pharmacol Sci 2024; DOI: 10.26355/eurrev_202408_36637 AbstractObjective: Pulmonary hypertension in the newborn (PPHN) is a significant clinical condition characterized by elevated pulmonary artery pressures, leading to serious health consequences. Magnesium sulfate, known for its vasodilatory

Intravenous magnesium sulfate in pulmonary hypertension of the newborn: a systematic review Read More »

Scroll to Top